Requirement for Arf6 in Breast Cancer Invasive Activities

• Published in: Proceedings of the National Academy of Sciences - PNAS 2004-04, Vol.101 (17), p.6647-6652
• Main Authors: Hashimoto, Shigeru, Onodera, Yasuhito, Hashimoto, Ari, Tanaka, Miwa, Hamaguchi, Michinari, Yamada, Atsuko, Sabe, Hisataka, Hanafusa, Hidesaburo
• Format: Article
• Language: English
• Subjects: 3T3 cells; ADP-Ribosylation Factors - genetics; ADP-Ribosylation Factors - physiology; Antibodies; Base Sequence; Biological Sciences; Breast cancer; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Breast Neoplasms - physiopathology; Cell Line, Tumor; Cell lines; Cells; Complementary DNA; Correlation analysis; Cultured cells; DNA Primers; DNA, Complementary; Gelatins; Genotype & phenotype; HeLa cells; Humans; Neoplasm Invasiveness; Polymerase Chain Reaction; Protein Isoforms - physiology; Recycling; RNA, Messenger - genetics; RNA, Small Interfering - physiology; Small interfering RNA; Surgery
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.0401753101

In most human breast cancer cell lines, there is a direct correlation between their in vivo invasive phenotypes and in vitro invasion activities. Here, we found that ADP-ribosylation factor 6 (Arf6) is localized at the invadopodia of the cultured breast cancer cells MDA-MB-231, and its suppression by a small-interfering RNA duplex effectively blocks the invasive activities of the cells, such as invadopodia formation, localized matrix degradation and Matrigel transmigration but not the cell-adhesion activity. We also found that the GTP hydrolysis-defective mutant Arf6(Q67L) and the GTP-binding defective mutant Arf6(T27N) both blocked these invasive activities but not cell adhesion, suggesting the necessity of continued activation and cycling of the Arf6 GTPase cycle in invasion. Among the different human breast cancer cell lines that we examined, cell lines with high invasive activities expressed higher amounts of Arf6 protein than those in weakly invasive and noninvasive cell lines, although no notable correlation was found between Arf6 mRNA expression levels and invasive activities. Moreover, Matrigel-transmigration activity of all of these invasive cells was blocked effectively by an Arf6 small-interfering RNA duplex. Hence, Arf6 appears to be an integral component of breast cancer invasive activities, and we propose that Arf6 and the intracellular machinery regulating Arf6 during invasion should be considered as therapeutic targets for the prevention of breast cancer invasion.